<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://vitalspanwire.com/news/sting-immune-signaling-bone-loss-aging-mice</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-16T11:01:59.680Z</news:publication_date><news:title>Mouse study links STING immune signaling to age-related bone loss</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/tryptophan-crosslinked-peptide-synthesis-research</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-15T21:02:19.873Z</news:publication_date><news:title>New synthesis method expands access to complex ring-shaped peptides</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/vasspr-vasopressin-septic-shock-survival-trial</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-15T16:02:18.182Z</news:publication_date><news:title>Earlier vasopressin strategy fails to improve survival in septic shock trial</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/srsf1-aging-frailty-mouse-lifespan-study</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-15T11:02:23.433Z</news:publication_date><news:title>SRSF1 study reports slower frailty progression and longer lifespan in mice</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/pepopt-interpretable-modeling-peptide-drug-design</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-14T21:01:58.915Z</news:publication_date><news:title>PepOpt study introduces interpretable modeling for peptide drug design</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/tovinontrine-heart-failure-biomarker-cycle-trials</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-14T16:02:17.433Z</news:publication_date><news:title>Tovinontrine misses heart-failure biomarker endpoint in preserved-ejection-fraction trial</news:title></news:news></url></urlset>